Novatek Requalified as an “Approved Supplier” for Boehringer Ingelheim Aseptic Manufacturing Facilities


Novatek requalifies as Boehringer Ingelheim approved supplier

Novatek has been requalified as an approved supplier for Boehringer Ingelheim. The company’s environment control solutions are used by Boehringer Ingelheim for its human pharma, animal health and biopharmaceutical aseptic (sterile) manufacturing sites worldwide.

The company’s products are designed to assist in managing critical aspects of a quality-controlled environment. Its software is a process specific solution which aims to meet each client’s user requirements.

Novatek’s environmental monitoring (EM) software helps companies like Boehringer Ingelheim, with portfolios that include veterinary therapeutics, aseptic manufacturing and vaccines, move towards a dedicated risk-based approach for their EM programs. The EM software can be used for labelling, collection, and tracking of environmental monitoring samples in the cleanroom environments, to provide a robust cleanroom data management system for the entire microbiological environmental monitoring process.

“We are excited to announce that Novatek is requalified as an approved supplier of Boehringer Ingelheim, for Novatek’s Environmental Monitoring Software around the world” said Mazda Famili, VP Quality at Novatek International. “We look forward to supporting Boehringer Ingelheim throughout their growth.”

About Novatek International

About Novatek International

Established in 1996, Novatek’s mission is dedicated to help pharmaceutical companies, vaccine manufacturers and other life science organizations leverage their investment in information technology and quality processes by reducing cost, improving productivity, and enhancing compliance. With 20+ years of user experience and developer level technical support, simple or complex installations are seamless and rapid. The architecture of all Novatek solutions are out of the box, modular and process-based, enabling the applications to be delivered “business-ready” providing the building blocks for a complete quality solution. For more information on Novatek International visit: and follow us on Twitter, LinkedIn, and Facebook.

About Boehringer Ingelheim

About Boehringer Ingelheim

Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven pharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Learn more at

SOURCE Novatek International

Related Links